$220 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 42 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | Exit | MERCK & CO INC | $0 | – | -70 | -100.0% | -0.00% | – |
| PEP | Exit | PEPSICO INC | $0 | – | -62 | -100.0% | -0.01% | – |
| IBKR | Exit | INTERACTIVE BROKERS GROUP INC | $0 | – | -145 | -100.0% | -0.01% | – |
| WMT | Exit | WALMART INC | $0 | – | -75 | -100.0% | -0.01% | – |
| INTU | Exit | INTUIT INC | $0 | – | -19 | -100.0% | -0.01% | – |
| UBER | Exit | UBER TECHNOLOGIES INC | $0 | – | -284 | -100.0% | -0.01% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -88 | -100.0% | -0.01% | – |
| Exit | GENERAL ELECTRIC CO | $0 | – | -137 | -100.0% | -0.01% | – | |
| AMT | Exit | AMERICAN TOWER CORPfunds, real estate investment trusts, domestic | $0 | – | -60 | -100.0% | -0.01% | – |
| MSCI | Exit | MSCI INC | $0 | – | -30 | -100.0% | -0.01% | – |
| DHR | Exit | DANAHER CORP | $0 | – | -60 | -100.0% | -0.01% | – |
| DG | Exit | DOLLAR GENERAL CORP | $0 | – | -88 | -100.0% | -0.01% | – |
| APD | Exit | AIR PRODUCTS & CHEMICALS INC | $0 | – | -81 | -100.0% | -0.01% | – |
| SCHW | Exit | CHARLES SCHWAB CORP/THE | $0 | – | -355 | -100.0% | -0.02% | – |
| TSLA | Exit | TESLA INC | $0 | – | -35 | -100.0% | -0.02% | – |
| V | Exit | VISA INC | $0 | – | -117 | -100.0% | -0.02% | – |
| PG | Exit | PROCTER & GAMBLE CO/THE | $0 | – | -207 | -100.0% | -0.02% | – |
| GOOGL | Exit | ALPHABET INC | $0 | – | -18 | -100.0% | -0.03% | – |
| FB | Exit | META PLATFORMS INC | $0 | – | -150 | -100.0% | -0.03% | – |
| GOOG | Exit | ALPHABET INC | $0 | – | -29 | -100.0% | -0.04% | – |
| BA | Exit | BOEING CO/THE | $0 | – | -450 | -100.0% | -0.06% | – |
| SOLY | Exit | SOLITON INC | $0 | – | -75,000 | -100.0% | -0.87% | – |
| DNLI | Exit | DENALI THERAPEUTICS INC | $0 | – | -41,918 | -100.0% | -1.21% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -126,904 | -100.0% | -29.41% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4/A | 2024-05-14 |
| 4 | 2024-05-01 |
| 3 | 2024-04-30 |
| 13F-HR | 2024-04-30 |
| 144 | 2024-04-29 |
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-04 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.